ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
TSX:AND - CA0342231077 - Common Stock
53.37 CAD
-0.02 (-0.04%)
We assign a fundamental rating of 6 out of 10 to AND. AND was compared to 15 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making AND a very profitable company, without any liquidiy or solvency issues. AND is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
AND had a positive operating cash flow in the past year.
In the past 5 years AND has always been profitable.
AND had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 9.81%, AND is doing good in the industry, outperforming 80.00% of the companies in the same industry.
The Return On Equity of AND (15.35%) is better than 86.67% of its industry peers.
With an excellent Return On Invested Capital value of 11.76%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AND is above the industry average of 7.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
The Profit Margin of AND (10.37%) is better than 86.67% of its industry peers.
In the last couple of years the Profit Margin of AND has remained more or less at the same level.
The Operating Margin of AND (13.99%) is better than 86.67% of its industry peers.
AND's Operating Margin has been stable in the last couple of years.
AND has a Gross Margin of 33.85%. This is in the lower half of the industry: AND underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of AND has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
AND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, AND has less shares outstanding
AND has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.98 indicates that AND is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.98, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
The Debt to FCF ratio of AND is 1.80, which is an excellent value as it means it would take AND, only 1.80 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AND (1.80) is better than 100.00% of its industry peers.
AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AND (0.21) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 5.98 |
ROIC/WACC1.48
WACC7.95%
2.3 Liquidity
AND has a Current Ratio of 1.35. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
AND has a Current ratio of 1.35. This is amongst the best in the industry. AND outperforms 93.33% of its industry peers.
AND has a Quick Ratio of 1.30. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.30, AND belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
AND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.96%.
The Earnings Per Share has been growing by 14.82% on average over the past years. This is quite good.
Looking at the last year, AND shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
AND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.53% yearly.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
The Earnings Per Share is expected to grow by 8.80% on average over the next years. This is quite good.
AND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.09% yearly.
EPS Next Y7.39%
EPS Next 2Y10.35%
EPS Next 3Y8.8%
EPS Next 5YN/A
Revenue Next Year0.27%
Revenue Next 2Y1.98%
Revenue Next 3Y2.09%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 34.21, the valuation of AND can be described as expensive.
Based on the Price/Earnings ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.02. AND is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 27.74, which means the current valuation is very expensive for AND.
AND's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AND to the average of the S&P500 Index (22.66), we can say AND is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.21 | ||
| Fwd PE | 27.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
AND's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.06 | ||
| EV/EBITDA | 13.65 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)4.63
PEG (5Y)2.31
EPS Next 2Y10.35%
EPS Next 3Y8.8%
5. Dividend
5.1 Amount
With a yearly dividend of 0.90%, AND is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.35, AND pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, AND's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
The dividend of AND decreases each year by -34.89%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
26.73% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP26.73%
EPS Next 2Y10.35%
EPS Next 3Y8.8%
TSX:AND (9/8/2025, 7:00:00 PM)
53.37
-0.02 (-0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.65%
Inst Owner ChangeN/A
Ins Owners2.37%
Ins Owner ChangeN/A
Market Cap2.09B
Analysts50
Price Target56.92 (6.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-5.71%
EPS NQ rev (3m)-7.3%
EPS NY rev (1m)-5.26%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)-2.58%
Revenue NQ rev (3m)-3.2%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-3.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.21 | ||
| Fwd PE | 27.74 | ||
| P/S | 3.21 | ||
| P/FCF | 21.06 | ||
| P/OCF | 17.08 | ||
| P/B | 4.75 | ||
| P/tB | 16.54 | ||
| EV/EBITDA | 13.65 |
EPS(TTM)1.56
EY2.92%
EPS(NY)1.92
Fwd EY3.61%
FCF(TTM)2.53
FCFY4.75%
OCF(TTM)3.13
OCFY5.86%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)4.63
PEG (5Y)2.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROCE | 16.09% | ||
| ROIC | 11.76% | ||
| ROICexc | 13.13% | ||
| ROICexgc | 34.45% | ||
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% | ||
| FCFM | 15.25% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexcg growth 3Y-1.36%
ROICexcg growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.6% | ||
| Profit Quality | 147.02% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 5.98 |
F-Score5
WACC7.95%
ROIC/WACC1.48
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y7.39%
EPS Next 2Y10.35%
EPS Next 3Y8.8%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.27%
Revenue Next 2Y1.98%
Revenue Next 3Y2.09%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year82.63%
EBIT Next 3Y25.61%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%